drugset / Trial / NCT03530930
Comarum Palustre in Knee Osteoarthritis and Diabetes
Phase 4
Completed
15 enrolled
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology
NaSingle-groupOpen-labelTreatment
Summary
The study evaluates analgesic, antiinflammatory and metabolic effects of Comarum palustre in patients with knee osteoarthritis (OA) and diabetes mellitus. Patients with osteoarthritis will receive Comarum palustre together with conventional treatment of osteoarthritis and diabetes.
Timeline
- Start
- 2018-06-29
- Primary completion
- 2018-11-25
- Completion
- 2018-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Comarum Palustre | Unknown | 500 mg | — |